Discover the long-term safety of brazikumab in patients with Crohn's disease during the open-label phase of a randomized phase 2a study. Gain insights into the treatment's impact, safety profile, and potential for managing Crohn's disease effectively. Watch this video to learn more about the findings and their implications for patient care.
Like
Comments
Save
Share
Comments